{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T22:59:30Z","timestamp":1780441170493,"version":"3.54.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100006260","name":"\u2018Rheumatology Research Foundation\u2019","doi-asserted-by":"crossref","award":["RRF-2014\u201301"],"award-info":[{"award-number":["RRF-2014\u201301"]}],"id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine the risk factors for herpes zoster (HZ) in patients with rheumatic diseases in Korea.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We used the nationwide database of the Health Insurance Review &amp; Assessment Service to analyse patients aged \u226520\u2009years who had visited a hospital more than twice for rheumatic disease as a principal diagnosis from January 2009 to April 2013. HZ was identified using HZ-related Korean Standard Classification of Diseases 6 (KCD-6) codes and the prescription of antiviral agents. The relationship between demographics, comorbidities and medications and HZ risk was analysed by Cox proportional hazards models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>HZ developed in 1869 patients. In Cox proportional hazards models, female sex but not age showed an increased adjusted hazard ratio (HR) for HZ. Comorbidities such as haematologic malignancies, hypertension, diabetes mellitus, and chronic lung and liver diseases led to an increased HR. HZ risk was higher in patients with SLE (HR: 4.29, 95% CI: 3.49, 5.27) and Beh\u00e7et\u2019s syndrome (BS, HR: 4.54; 95% CI: 3.66, 5.64) than with RA. The use of conventional DMARDs, immunosuppressants, TNF inhibitors, glucocorticoids and NSAIDs increased the HR. Infliximab and glucocorticoids (equivalent prednisolone dose &amp;gt;15\u2009mg\/day) produced the highest HZ risk (HR: 2.91, 95% CI: 1.72, 4.89; HR: 2.85, 95% CI: 2.15, 3.77, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Female sex, comorbidities and medications increased HZ risk in patients with rheumatic diseases and even young patients could develop HZ. Compared with RA, SLE and BS are stronger HZ risk factors. Patients with rheumatic diseases and these risk factors are potential target populations for HZ vaccination.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa636","type":"journal-article","created":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T19:13:48Z","timestamp":1599592428000},"page":"2427-2433","source":"Crossref","is-referenced-by-count":17,"title":["Risk factors for herpes zoster in patients with rheumatic diseases: a nationwide cohort study in Korea"],"prefix":"10.1093","volume":"60","author":[{"given":"Hee Jung","family":"Ryu","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Gachon University College of Medicine, Gil Medical Center, Incheon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ok","family":"Han","sequence":"additional","affiliation":[{"name":"Gyeonggi Public Health Policy Institute, Seongnam-si, Gyeonggi-do"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Ah","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Gachon University College of Medicine, Gil Medical Center, Incheon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Ryoung","family":"Seo","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Gachon University College of Medicine, Gil Medical Center, Incheon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Gachon University College of Medicine, Gil Medical Center, Incheon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Pil","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Gachon University College of Medicine, Incheon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Joo","family":"Baek","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Gachon University College of Medicine, Gil Medical Center, Incheon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"2021051418583839500_keaa636-B1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.idc.2017.07.016","article-title":"Herpes zoster in the older adult","volume":"31","author":"John","year":"2017","journal-title":"Infect Dis Clin North Am"},{"key":"2021051418583839500_keaa636-B2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/v10110609","article-title":"Clinical features of varicella-zoster virus infection","volume":"10","author":"Kennedy","year":"2018","journal-title":"Viruses"},{"key":"2021051418583839500_keaa636-B3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7015-8-37","article-title":"The impact of herpes zoster and post-herpetic neuralgia on quality-of-life","volume":"8","author":"Johnson","year":"2010","journal-title":"BMC Med"},{"key":"2021051418583839500_keaa636-B4","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"2021051418583839500_keaa636-B5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12879-017-2198-y","article-title":"Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific","volume":"17","author":"Chen","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2021051418583839500_keaa636-B6","doi-asserted-by":"crossref","first-page":"ofw119","DOI":"10.1093\/ofid\/ofw119","article-title":"Risk factors for herpes zoster among adults","volume":"3","author":"Marin","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2021051418583839500_keaa636-B7","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.mayocp.2017.10.009","article-title":"Risk factors for herpes zoster: a systematic review and meta-analysis","volume":"92","author":"Kawai","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"2021051418583839500_keaa636-B8","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/WNL.0b013e3182a3516e","article-title":"The global epidemiology of herpes zoster","volume":"81","author":"Yawn","year":"2013","journal-title":"Neurology"},{"key":"2021051418583839500_keaa636-B9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jbspin.2016.04.001","article-title":"Herpes zoster: risk and prevention during immunomodulating therapy","volume":"84","author":"Tran","year":"2017","journal-title":"Joint Bone Spine"},{"key":"2021051418583839500_keaa636-B10","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"2021051418583839500_keaa636-B11","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2021051418583839500_keaa636-B12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2021051418583839500_keaa636-B13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s15010-011-0162-0","article-title":"Risk of herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study","volume":"39","author":"Hata","year":"2011","journal-title":"Infection"},{"key":"2021051418583839500_keaa636-B14","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.39670","article-title":"Risk of herpes zoster in autoimmune and inflammatory diseases: implications for vaccination","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2021051418583839500_keaa636-B15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/1756-185X.13650","article-title":"The risk of herpes zoster among patients with ankylosing spondylitis: a population-based cohort study in Taiwan","volume":"23","author":"Wang","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"2021051418583839500_keaa636-B16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/1756-185X.13694","article-title":"Risk of cutaneous herpes zoster in patients with spondyloarthritis treated with conventional and biologic disease-modifying antirheumatic drugs","volume":"23","author":"Wong","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"2021051418583839500_keaa636-B17","doi-asserted-by":"crossref","first-page":"e014032","DOI":"10.1136\/bmjopen-2016-014032","article-title":"Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia","volume":"7","author":"Liao","year":"2017","journal-title":"BMJ Open"},{"key":"2021051418583839500_keaa636-B18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaad.2015.12.059","article-title":"Immunosuppressive medication use and risk of herpes zoster (Hz) in patients with systemic lupus erythematosus (SLE): a nationwide case-control study","volume":"75","author":"Hu","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"2021051418583839500_keaa636-B19","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/acr.22628","article-title":"Herpes zoster reactivation in patients with rheumatoid arthritis: analysis of disease characteristics and disease-modifying antirheumatic drugs","volume":"67","author":"Pappas","year":"2015","journal-title":"Arthritis Care Res"},{"key":"2021051418583839500_keaa636-B20","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/1756-185X.13300","article-title":"No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database","volume":"21","author":"Sakai","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"2021051418583839500_keaa636-B21","doi-asserted-by":"crossref","first-page":"ofw205","DOI":"10.1093\/ofid\/ofw205","article-title":"Risk of herpes zoster in individuals on biologics, disease-modifying antirheumatic drugs, and\/or corticosteroids for autoimmune diseases: a systematic review and meta-analysis","volume":"3","author":"Marra","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2021051418583839500_keaa636-B22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jama.2013.1099","article-title":"Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster","volume":"309","author":"Winthrop","year":"2013","journal-title":"JAMA"},{"key":"2021051418583839500_keaa636-B23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/imj.12679","article-title":"Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-\u03b1 inhibitors","volume":"45","author":"Segan","year":"2015","journal-title":"Intern Med J"},{"key":"2021051418583839500_keaa636-B24","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/rheumatology\/kel328","article-title":"Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders","volume":"45","author":"Wolfe","year":"2006","journal-title":"Rheumatology"},{"key":"2021051418583839500_keaa636-B25","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2021051418583839500_keaa636-B26","first-page":"341","article-title":"VZV T cell-mediated immunity","volume":"342","author":"Weinberg","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"2021051418583839500_keaa636-B27","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/jid.2015.63","article-title":"The characterization of varicella zoster virus-specific T cells in skin and blood during aging","volume":"135","author":"Vukmanovic-Stejic","year":"2015","journal-title":"J Invest Dermatol"},{"key":"2021051418583839500_keaa636-B28","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1086\/651199","article-title":"Influence of age and nature of primary infection on varicella-zoster virus\u2013specific cell-mediated immune responses","volume":"201","author":"Weinberg","year":"2010","journal-title":"J Infect Dis"},{"key":"2021051418583839500_keaa636-B29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13075-018-1742-5","article-title":"VZV-specific T-cell levels in patients with rheumatic diseases are reduced and differentially influenced by antirheumatic drugs","volume":"20","author":"Schub","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2021051418583839500_keaa636-B30","first-page":"2151","article-title":"Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus","volume":"31","author":"Park","year":"2004","journal-title":"J Rheumatol"},{"key":"2021051418583839500_keaa636-B31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0166-3542(91)90065-Y","article-title":"Effects of tumor necrosis factor alpha on replication of varicella-zoster virus","volume":"15","author":"Ito","year":"1991","journal-title":"Antiviral Res"},{"key":"2021051418583839500_keaa636-B32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2125.2007.02997.x","article-title":"Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease","volume":"65","author":"Mikaeloff","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"2021051418583839500_keaa636-B33","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/infdis\/152.4.690","article-title":"Effects of the newer nonsteroidal anti-inflammatory agents, ibuprofen, fenoprofen, and sulindac, on neutrophil adherence","volume":"152","author":"Venezio","year":"1985","journal-title":"J Infect Dis"},{"key":"2021051418583839500_keaa636-B34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1592\/phco.25.1.18.55618","article-title":"Relationships between the concentrations of prostaglandins and the nonsteroidal antiinflammatory drugs indomethacin, diclofenac, and ibuprofen","volume":"25","author":"Giagoudakis","year":"2005","journal-title":"Pharmacotherapy"},{"key":"2021051418583839500_keaa636-B35","first-page":"1528","article-title":"Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021051418583839500_keaa636-B36"},{"key":"2021051418583839500_keaa636-B37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"Van Assen","year":"2011","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/5\/2427\/37935749\/keaa636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/5\/2427\/37935749\/keaa636.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T18:59:09Z","timestamp":1621018749000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/5\/2427\/6000239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,11,24]]},"published-print":{"date-parts":[[2021,5,14]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa636","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2020,11,24]]}}}